The Direct Molecular Target for Imipridone ONC201 Is Finally Established
- PMID: 31085171
- DOI: 10.1016/j.ccell.2019.04.010
The Direct Molecular Target for Imipridone ONC201 Is Finally Established
Abstract
In this issue of Cancer Cell, Ishizawa et al. describe the hyperactivation of ClpP as a strategy in cancer therapy. They discovered ONC201, a clinical-stage compound, as a potent activator of ClpP and established that ClpP activation is responsible for the antitumor activity of imipridone ONC201.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment on
-
Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.Cancer Cell. 2019 May 13;35(5):721-737.e9. doi: 10.1016/j.ccell.2019.03.014. Epub 2019 May 2. Cancer Cell. 2019. PMID: 31056398 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
